156. Rett syndrome Clinical trials / Disease details
Clinical trials : 44 / Drugs : 61 - (DrugBank : 23) / Drug target genes : 57 - Drug target pathways : 83
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04041713 (ClinicalTrials.gov) | September 1, 2019 | 27/6/2019 | A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome | A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome | Rett Syndrome | Drug: Rett-T;Other: Placebo | Anagnostou, Evdokia, M.D. | Ontario Brain Institute;St. Michael's Hospital, Toronto;Holland Bloorview Kids Rehabilitation Hospital | Not yet recruiting | 2 Years | 21 Years | Female | 35 | Phase 2 | Canada |